The analysis from The Business Journals used data from the U.S. Department of Education to determine the most selective ...

Ongoing strength in the U.S. economy drove mortgage rates up over 7% for the first time in eight months, casting doubt over a recovery in the housing sector. The 30-year mortgage rate inched up to ...

Diversity rates at several elite colleges and universities have plummeted, a little over a year after the Supreme Court’s ...

The Bank of England looks set to resume cutting interest rates next month after official data revealed weaker inflation and anaemic economic growth. Economic output expanded by just 0.1 per cent ...

Concessionary fee £157 (find out about eligibility and funding options) Acceptance and Commitment Therapy (ACT ... As a student on this course you are entitled to join and use the University’s library ...

SOMERVILLE, Mass. — Professor Fiorenzo Omenetto and research assistant Marco Lo Presti and their team at Silklab create silk-based inventions that are inspired by nature, such as silk from ...

After climbing to its most expensive level in more than seven months, the 30-year mortgage rate average marched in place Tuesday at 7.13%. Rate movement was meanwhile mixed for other mortgage types.

Jan 15 (Reuters) - The interest rate for the most popular U.S. home loan rose last week to an eight-month high of 7.09%, extending an upward trend that's squeezing would-be homebuyers already ...

Prestigious institutions like New York University—Long Island and Virginia Tech Carilion School of Medicine have acceptance rates as low as 1.2% and 2.0%, respectively. Medical courses Pursuing ...

according to the University’s common data set. As a result of this rise in applications, UNC’s acceptance rate declined from 22.6 percent to 15.6 percent during that period. “The atmosphere ...

Inflation has cooled from its 2023 peak, but at 2.7%, today's rate is still above the Federal Reserve's 2% target. Meanwhile, interest rates are still high, and for homebuyers, this means mortgage ...

A major clinical trial, led by the University of Sheffield, has revealed survival rates for patients with operable bladder cancer are significantly improved by adding an immunotherapy drug to before ...